Trials / Completed
CompletedNCT01983111
Compare the Efficacy and Safety of Norspan to Tramadol/Acetaminophen With Prolonged Postoperative Pain (PASSION)
A Multicenter, Phase IV, Interventional Study to Compare the Efficacy and Safety of NORSPAN to Tramadol/Acetaminophen in Patients With Prolonged Postoperative Pain After Spinal Surgery (PASSION)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 136 (actual)
- Sponsor
- Mundipharma Korea Ltd · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy and safety of buprenorphine transdermal system to tramadol/acetaminophen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | buprenorphine | Dosage and administration: This one patch should be attached every 7 days. |
| DRUG | tramadol/acetaminophen | Amount of drug ingredients : Acetaminophen 325 mg and Tramadol hydrochloride 37.5 mg in 1 tablet of this drug. Dosage and administration: Adjust dose depending on a patient's pain severity and treatment response. Starting at the initial dose of 2 tablets, usually administer 4 tablets per dose, twice daily. At a dosing interval of at least 12 hr, the daily dose should not exceed 8 tablets. |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2014-11-01
- Completion
- 2014-11-01
- First posted
- 2013-11-13
- Last updated
- 2016-07-11
- Results posted
- 2016-07-11
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01983111. Inclusion in this directory is not an endorsement.